A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered Des-Aspartate Angiotensin I in Healthy Subjects View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-12

AUTHORS

Ko-Onn Lee, Chin-Meng Khoo, Balram Chowbay, Yiong-Huak Chan, Meng-Kwoon Sim

ABSTRACT

Des-aspartate-angiotensin I (DAA-I) is an endogenous angiotensin peptide and a prototype angiotensin receptor agonist (ARA). It acts on the angiotensin AT1 receptor and antagonises the deleterious actions of angiotensin II. DAA-I attenuates animal models of human disease in which angiotensin II has been implicated, such as cardiac hypertrophy, neointima formation, arteriosclerosis, renal failure, post-infarction injuries, diabetes, viral infection, chemical-induced inflammation, heat stroke, cancer, and gamma radiation lethality. DAA-I crosses Caco-2 cells and is effective at sub-nanomolar concentrations. These two properties are responsible for its oral efficacy. A single dose-escalation study was conducted to evaluate the safety, tolerability and pharmacokinetics of orally administered DAA-I in 18 healthy subjects. DAA-I was safe and well tolerated by the subjects, who were administered either 0.08, 0.70 or 1.50 mg/kg of the compound. The heart rate and systolic and diastolic blood pressures determined at each post-dose measurement remained within the clinically acceptable range. Across all cohorts, DAA-I had no substantial effect on blood pressures compared with placebo. Electrocardiographs (ECGs) were normal, and none of the subjects complained of chest discomfort. All clinical laboratory tests obtained before and after DAA-I and placebo treatment were normal. Pharmacokinetic analysis over a 12-h period following DAA-I administration did not show any increase of its level beyond basal concentration. This is in line with studies showing that intravenously administered DAA-I is rapidly metabolized and has a short half-life. We postulate that, during its short systemic sojourn, DAA-I exerts its actions via biased agonism on the angiotensin AT1 receptor.The ClinicalTrial.gov assignment number for this study is NCT02666196. More... »

PAGES

317-326

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s40268-016-0143-y

DOI

http://dx.doi.org/10.1007/s40268-016-0143-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1046699719

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27681888


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Oral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angiotensin I", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "National University of Singapore", 
          "id": "https://www.grid.ac/institutes/grid.4280.e", 
          "name": [
            "Department of Medicine, National University of Singapore, 1E Kent Ridge Road, NUHS Tower Block Level 10, 119228, Singapore, Singapore"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Ko-Onn", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National University of Singapore", 
          "id": "https://www.grid.ac/institutes/grid.4280.e", 
          "name": [
            "Department of Medicine, National University of Singapore, 1E Kent Ridge Road, NUHS Tower Block Level 10, 119228, Singapore, Singapore"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Khoo", 
        "givenName": "Chin-Meng", 
        "id": "sg:person.0740327705.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740327705.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke NUS Graduate Medical School", 
          "id": "https://www.grid.ac/institutes/grid.428397.3", 
          "name": [
            "Laboratory of Clinical Pharmacology, Division of Medical Sciences, Humphrey Oei Institute of Cancer Research, National Cancer Centre, Singapore, Singapore", 
            "Clinical Pharmacology Core, Sing Health, Singapore, Singapore", 
            "Office of Clinical Sciences, Duke-NUS Graduate Medical School Singapore, Singapore, Singapore"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chowbay", 
        "givenName": "Balram", 
        "id": "sg:person.0764625350.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0764625350.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National University of Singapore", 
          "id": "https://www.grid.ac/institutes/grid.4280.e", 
          "name": [
            "Biostatistics Unit, Yong Loo Lin School of Medicine, National University Health System, 1E Kent Ridge Road, NUHS Tower Block Level 11, 119228, Singapore, Singapore"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chan", 
        "givenName": "Yiong-Huak", 
        "id": "sg:person.010350321634.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010350321634.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National University of Singapore", 
          "id": "https://www.grid.ac/institutes/grid.4280.e", 
          "name": [
            "Department of Pharmacology, Yong Loo Lin School of Medicine, Block MD 3 Level 4 #04-01, 16\u00a0Medical Drive, 117600, Singapore, Singapore"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sim", 
        "givenName": "Meng-Kwoon", 
        "id": "sg:person.01131306647.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01131306647.73"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/0006-2952(78)90203-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003538612"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(78)90203-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003538612"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.regpep.2003.12.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004400639"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(94)90376-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004432724"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(94)90376-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004432724"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0167-5273(97)00324-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010550930"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.peptides.2004.06.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011113990"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0167-0115(02)00289-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017831393"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0167-0115(02)00289-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017831393"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.regpep.2005.02.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029781474"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejphar.2011.02.014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032642828"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejphar.2015.10.051", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033314164"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.tips.2010.02.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033740199"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0138009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033760351"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.mce.2013.11.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036121432"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(93)90054-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038201718"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(93)90054-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038201718"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.regpep.2003.10.030", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039299596"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.res.0000242563.47507.ce", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040871863"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.res.0000242563.47507.ce", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040871863"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bcp.2011.07.080", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045291364"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1124/mol.114.097030", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046745135"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jat.1599", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047657209"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejphar.2015.04.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049651874"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.regpep.2004.03.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050213526"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1530/eje.0.1460863", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052116450"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1530/eje.0.1460863", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052116450"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1530/eje.0.1460863", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052116450"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/en.2007-0606", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064248739"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jcem-50-1-40", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064310934"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-12", 
    "datePublishedReg": "2016-12-01", 
    "description": "Des-aspartate-angiotensin I (DAA-I) is an endogenous angiotensin peptide and a prototype angiotensin receptor agonist (ARA). It acts on the angiotensin AT1 receptor and antagonises the deleterious actions of angiotensin II. DAA-I attenuates animal models of human disease in which angiotensin II has been implicated, such as cardiac hypertrophy, neointima formation, arteriosclerosis, renal failure, post-infarction injuries, diabetes, viral infection, chemical-induced inflammation, heat stroke, cancer, and gamma radiation lethality. DAA-I crosses Caco-2 cells and is effective at sub-nanomolar concentrations. These two properties are responsible for its oral efficacy. A single dose-escalation study was conducted to evaluate the safety, tolerability and pharmacokinetics of orally administered DAA-I in 18 healthy subjects. DAA-I was safe and well tolerated by the subjects, who were administered either 0.08, 0.70 or 1.50\u00a0mg/kg of the compound. The heart rate and systolic and diastolic blood pressures determined at each post-dose measurement remained within the clinically acceptable range. Across all cohorts, DAA-I had no substantial effect on blood pressures compared with placebo. Electrocardiographs (ECGs) were normal, and none of the subjects complained of chest discomfort. All clinical laboratory tests obtained before and after DAA-I and placebo treatment were normal. Pharmacokinetic analysis over a 12-h period following DAA-I administration did not show any increase of its level beyond basal concentration. This is in line with studies showing that intravenously administered DAA-I is rapidly metabolized and has a short half-life. We postulate that, during its short systemic sojourn, DAA-I exerts its actions via biased agonism on the angiotensin AT1 receptor.The ClinicalTrial.gov assignment number for this study is NCT02666196.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s40268-016-0143-y", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1020803", 
        "issn": [
          "1174-5886", 
          "1179-6901"
        ], 
        "name": "Drugs in R&D", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "16"
      }
    ], 
    "name": "A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered Des-Aspartate Angiotensin I in Healthy Subjects", 
    "pagination": "317-326", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "de7598fd5c8eb16865be8c49dd3fdc4a52cfaf620d796e76d33501cca4ed9d02"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27681888"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100883647"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s40268-016-0143-y"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1046699719"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s40268-016-0143-y", 
      "https://app.dimensions.ai/details/publication/pub.1046699719"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:40", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000363_0000000363/records_70049_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs40268-016-0143-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s40268-016-0143-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s40268-016-0143-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s40268-016-0143-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s40268-016-0143-y'


 

This table displays all metadata directly associated to this object as RDF triples.

208 TRIPLES      21 PREDICATES      61 URIs      30 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s40268-016-0143-y schema:about N48f3260c2bec4863805ce6bd732a2412
2 N557fecaa70b949cf9c5a359a09193f0b
3 N9554fc1010984fd5a18e4b4e7ebd8cb7
4 N9a2bfaf9128c4c5a878a3d8226e778c8
5 N9f108240160a4de0ad5e37f7812f2bdf
6 Nb564b01ecfa34685a229dda84e56b0ba
7 Ncb49e4cc4eb94b57a8c7a26e16f29ae2
8 Nd4d948fd9ba14d038de371e90fa60911
9 Nfefe1a8975a44c8ebd6e64ce8a371bbc
10 anzsrc-for:11
11 anzsrc-for:1102
12 schema:author Ne7642617ea0c413c94fe4d2de34ec595
13 schema:citation https://doi.org/10.1002/jat.1599
14 https://doi.org/10.1016/0006-2952(78)90203-4
15 https://doi.org/10.1016/0006-2952(93)90054-z
16 https://doi.org/10.1016/0006-2952(94)90376-x
17 https://doi.org/10.1016/j.bcp.2011.07.080
18 https://doi.org/10.1016/j.ejphar.2011.02.014
19 https://doi.org/10.1016/j.ejphar.2015.04.004
20 https://doi.org/10.1016/j.ejphar.2015.10.051
21 https://doi.org/10.1016/j.mce.2013.11.010
22 https://doi.org/10.1016/j.peptides.2004.06.009
23 https://doi.org/10.1016/j.regpep.2003.10.030
24 https://doi.org/10.1016/j.regpep.2003.12.010
25 https://doi.org/10.1016/j.regpep.2004.03.003
26 https://doi.org/10.1016/j.regpep.2005.02.007
27 https://doi.org/10.1016/j.tips.2010.02.002
28 https://doi.org/10.1016/s0167-0115(02)00289-6
29 https://doi.org/10.1016/s0167-5273(97)00324-0
30 https://doi.org/10.1124/mol.114.097030
31 https://doi.org/10.1161/01.res.0000242563.47507.ce
32 https://doi.org/10.1210/en.2007-0606
33 https://doi.org/10.1210/jcem-50-1-40
34 https://doi.org/10.1371/journal.pone.0138009
35 https://doi.org/10.1530/eje.0.1460863
36 schema:datePublished 2016-12
37 schema:datePublishedReg 2016-12-01
38 schema:description Des-aspartate-angiotensin I (DAA-I) is an endogenous angiotensin peptide and a prototype angiotensin receptor agonist (ARA). It acts on the angiotensin AT<sub>1</sub> receptor and antagonises the deleterious actions of angiotensin II. DAA-I attenuates animal models of human disease in which angiotensin II has been implicated, such as cardiac hypertrophy, neointima formation, arteriosclerosis, renal failure, post-infarction injuries, diabetes, viral infection, chemical-induced inflammation, heat stroke, cancer, and gamma radiation lethality. DAA-I crosses Caco-2 cells and is effective at sub-nanomolar concentrations. These two properties are responsible for its oral efficacy. A single dose-escalation study was conducted to evaluate the safety, tolerability and pharmacokinetics of orally administered DAA-I in 18 healthy subjects. DAA-I was safe and well tolerated by the subjects, who were administered either 0.08, 0.70 or 1.50 mg/kg of the compound. The heart rate and systolic and diastolic blood pressures determined at each post-dose measurement remained within the clinically acceptable range. Across all cohorts, DAA-I had no substantial effect on blood pressures compared with placebo. Electrocardiographs (ECGs) were normal, and none of the subjects complained of chest discomfort. All clinical laboratory tests obtained before and after DAA-I and placebo treatment were normal. Pharmacokinetic analysis over a 12-h period following DAA-I administration did not show any increase of its level beyond basal concentration. This is in line with studies showing that intravenously administered DAA-I is rapidly metabolized and has a short half-life. We postulate that, during its short systemic sojourn, DAA-I exerts its actions via biased agonism on the angiotensin AT<sub>1</sub> receptor.The ClinicalTrial.gov assignment number for this study is NCT02666196.
39 schema:genre research_article
40 schema:inLanguage en
41 schema:isAccessibleForFree true
42 schema:isPartOf N257c30be2b394391af2e4a8d6d3ca616
43 N77f0f367ea344fd69b094b4b730d70cb
44 sg:journal.1020803
45 schema:name A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered Des-Aspartate Angiotensin I in Healthy Subjects
46 schema:pagination 317-326
47 schema:productId N8af24addb036417a9e00df55648eaddf
48 N9352a12b9c154477beb50a92a3e165b8
49 N98e01a9c19774643b19ae433afdf6623
50 Nb388a82935734721a2460770afc8df65
51 Neb2cfd4b28654f49aa1f34f253f4c790
52 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046699719
53 https://doi.org/10.1007/s40268-016-0143-y
54 schema:sdDatePublished 2019-04-11T12:40
55 schema:sdLicense https://scigraph.springernature.com/explorer/license/
56 schema:sdPublisher N3f37163ca2fe42d28f3dc4a7c6ada77a
57 schema:url https://link.springer.com/10.1007%2Fs40268-016-0143-y
58 sgo:license sg:explorer/license/
59 sgo:sdDataset articles
60 rdf:type schema:ScholarlyArticle
61 N257c30be2b394391af2e4a8d6d3ca616 schema:issueNumber 4
62 rdf:type schema:PublicationIssue
63 N2821bbce3c604bd8a48d4f7f5a755cbf rdf:first sg:person.01131306647.73
64 rdf:rest rdf:nil
65 N3f37163ca2fe42d28f3dc4a7c6ada77a schema:name Springer Nature - SN SciGraph project
66 rdf:type schema:Organization
67 N48f3260c2bec4863805ce6bd732a2412 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Adult
69 rdf:type schema:DefinedTerm
70 N557fecaa70b949cf9c5a359a09193f0b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Male
72 rdf:type schema:DefinedTerm
73 N594012e6baf94849b540216d734c2132 schema:affiliation https://www.grid.ac/institutes/grid.4280.e
74 schema:familyName Lee
75 schema:givenName Ko-Onn
76 rdf:type schema:Person
77 N77f0f367ea344fd69b094b4b730d70cb schema:volumeNumber 16
78 rdf:type schema:PublicationVolume
79 N7afbcfa7796c466c97827ae9d9674317 rdf:first sg:person.010350321634.52
80 rdf:rest N2821bbce3c604bd8a48d4f7f5a755cbf
81 N8af24addb036417a9e00df55648eaddf schema:name pubmed_id
82 schema:value 27681888
83 rdf:type schema:PropertyValue
84 N9352a12b9c154477beb50a92a3e165b8 schema:name doi
85 schema:value 10.1007/s40268-016-0143-y
86 rdf:type schema:PropertyValue
87 N93e37a4a8f3f4e7e83f774fbcb27c561 rdf:first sg:person.0764625350.94
88 rdf:rest N7afbcfa7796c466c97827ae9d9674317
89 N9554fc1010984fd5a18e4b4e7ebd8cb7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Humans
91 rdf:type schema:DefinedTerm
92 N98e01a9c19774643b19ae433afdf6623 schema:name nlm_unique_id
93 schema:value 100883647
94 rdf:type schema:PropertyValue
95 N9a2bfaf9128c4c5a878a3d8226e778c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Young Adult
97 rdf:type schema:DefinedTerm
98 N9f108240160a4de0ad5e37f7812f2bdf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Middle Aged
100 rdf:type schema:DefinedTerm
101 Nb388a82935734721a2460770afc8df65 schema:name readcube_id
102 schema:value de7598fd5c8eb16865be8c49dd3fdc4a52cfaf620d796e76d33501cca4ed9d02
103 rdf:type schema:PropertyValue
104 Nb3cfc949e8c749dcb7b8fb5525ea60c4 rdf:first sg:person.0740327705.02
105 rdf:rest N93e37a4a8f3f4e7e83f774fbcb27c561
106 Nb564b01ecfa34685a229dda84e56b0ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Angiotensin I
108 rdf:type schema:DefinedTerm
109 Ncb49e4cc4eb94b57a8c7a26e16f29ae2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Female
111 rdf:type schema:DefinedTerm
112 Nd4d948fd9ba14d038de371e90fa60911 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Dose-Response Relationship, Drug
114 rdf:type schema:DefinedTerm
115 Ne7642617ea0c413c94fe4d2de34ec595 rdf:first N594012e6baf94849b540216d734c2132
116 rdf:rest Nb3cfc949e8c749dcb7b8fb5525ea60c4
117 Neb2cfd4b28654f49aa1f34f253f4c790 schema:name dimensions_id
118 schema:value pub.1046699719
119 rdf:type schema:PropertyValue
120 Nfefe1a8975a44c8ebd6e64ce8a371bbc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Administration, Oral
122 rdf:type schema:DefinedTerm
123 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
124 schema:name Medical and Health Sciences
125 rdf:type schema:DefinedTerm
126 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
127 schema:name Cardiorespiratory Medicine and Haematology
128 rdf:type schema:DefinedTerm
129 sg:journal.1020803 schema:issn 1174-5886
130 1179-6901
131 schema:name Drugs in R&D
132 rdf:type schema:Periodical
133 sg:person.010350321634.52 schema:affiliation https://www.grid.ac/institutes/grid.4280.e
134 schema:familyName Chan
135 schema:givenName Yiong-Huak
136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010350321634.52
137 rdf:type schema:Person
138 sg:person.01131306647.73 schema:affiliation https://www.grid.ac/institutes/grid.4280.e
139 schema:familyName Sim
140 schema:givenName Meng-Kwoon
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01131306647.73
142 rdf:type schema:Person
143 sg:person.0740327705.02 schema:affiliation https://www.grid.ac/institutes/grid.4280.e
144 schema:familyName Khoo
145 schema:givenName Chin-Meng
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740327705.02
147 rdf:type schema:Person
148 sg:person.0764625350.94 schema:affiliation https://www.grid.ac/institutes/grid.428397.3
149 schema:familyName Chowbay
150 schema:givenName Balram
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0764625350.94
152 rdf:type schema:Person
153 https://doi.org/10.1002/jat.1599 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047657209
154 rdf:type schema:CreativeWork
155 https://doi.org/10.1016/0006-2952(78)90203-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003538612
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1016/0006-2952(93)90054-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1038201718
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1016/0006-2952(94)90376-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1004432724
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1016/j.bcp.2011.07.080 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045291364
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1016/j.ejphar.2011.02.014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032642828
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1016/j.ejphar.2015.04.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049651874
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1016/j.ejphar.2015.10.051 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033314164
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1016/j.mce.2013.11.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036121432
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1016/j.peptides.2004.06.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011113990
172 rdf:type schema:CreativeWork
173 https://doi.org/10.1016/j.regpep.2003.10.030 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039299596
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1016/j.regpep.2003.12.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004400639
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1016/j.regpep.2004.03.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050213526
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1016/j.regpep.2005.02.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029781474
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1016/j.tips.2010.02.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033740199
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1016/s0167-0115(02)00289-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017831393
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1016/s0167-5273(97)00324-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010550930
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1124/mol.114.097030 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046745135
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1161/01.res.0000242563.47507.ce schema:sameAs https://app.dimensions.ai/details/publication/pub.1040871863
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1210/en.2007-0606 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064248739
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1210/jcem-50-1-40 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064310934
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1371/journal.pone.0138009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033760351
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1530/eje.0.1460863 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052116450
198 rdf:type schema:CreativeWork
199 https://www.grid.ac/institutes/grid.4280.e schema:alternateName National University of Singapore
200 schema:name Biostatistics Unit, Yong Loo Lin School of Medicine, National University Health System, 1E Kent Ridge Road, NUHS Tower Block Level 11, 119228, Singapore, Singapore
201 Department of Medicine, National University of Singapore, 1E Kent Ridge Road, NUHS Tower Block Level 10, 119228, Singapore, Singapore
202 Department of Pharmacology, Yong Loo Lin School of Medicine, Block MD 3 Level 4 #04-01, 16 Medical Drive, 117600, Singapore, Singapore
203 rdf:type schema:Organization
204 https://www.grid.ac/institutes/grid.428397.3 schema:alternateName Duke NUS Graduate Medical School
205 schema:name Clinical Pharmacology Core, Sing Health, Singapore, Singapore
206 Laboratory of Clinical Pharmacology, Division of Medical Sciences, Humphrey Oei Institute of Cancer Research, National Cancer Centre, Singapore, Singapore
207 Office of Clinical Sciences, Duke-NUS Graduate Medical School Singapore, Singapore, Singapore
208 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...